论文部分内容阅读
目的探讨和分析布地奈德联合异丙托溴铵雾化吸入治疗小儿支气管肺炎的效果。方法 100例小儿支气管肺炎患儿,随机分为观察组和对照组,每组50例。对照组患儿给予头孢呋辛治疗,观察组患儿给予布地奈德联合异丙托溴铵雾化吸入治疗,比较两组治疗效果。结果对照组患儿总有效率为84%,观察组患儿总有效率为98%,观察组患儿总有效率明显高于对照组,差异具有统计学意义(P<0.05)。观察组患儿的咳嗽停止时间、体温和X线恢复正常时间、平喘时间均明显短于对照组患儿,差异具有统计学意义(P<0.05)。结论布地奈德联合异丙托溴铵雾化吸入治疗小儿支气管肺炎具有非常明显的效果,能够在短时间内改善患儿的临床症状,对于小儿支气管疾病的治疗具有积极的临床指导价值。
Objective To investigate and analyze the effect of budesonide combined with ipratropium bromide inhalation on bronchial pneumonia in children. Methods 100 cases of children with bronchial pneumonia were randomly divided into observation group and control group, 50 cases in each group. The control group received cefuroxime, while the observation group received budesonide plus ipratropium bromide. The therapeutic effect was compared between the two groups. Results The total effective rate of children in the control group was 84%. The total effective rate in the observation group was 98%. The total effective rate in the observation group was significantly higher than that in the control group (P <0.05). The cough stop time, body temperature and normal time of X-ray recovery, asthma relief time in observation group were significantly shorter than those in control group, the difference was statistically significant (P <0.05). Conclusion Budesonide combined with ipratropium bromide inhalation treatment of children with bronchopneumonia has a very significant effect, can improve the clinical symptoms in children in a short time, for the treatment of children with bronchial disease has a positive clinical value.